Ignite Creation Date:
2024-05-06 @ 7:38 AM
Last Modification Date:
2024-10-26 @ 11:51 AM
Study NCT ID:
NCT02576379
Status:
COMPLETED
Last Update Posted:
2016-07-11
First Post:
2015-10-13
Brief Title:
The Impact of a Helicopter Emergency Medical System on Prognosis in Stroke Patients
Sponsor:
Rigshospitalet Denmark
Organization:
Rigshospitalet Denmark
Study Overview
Official Title:
The Impact of a Helicopter Emergency Medical System on Prognosis in Stroke Patients
Status:
COMPLETED
Status Verified Date:
2016-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Stroke is a leading cause of death and disability and 15 million people suffer a stroke each year one-third die and one-third are left permanently disabled Because the risk of stroke increases with age it has been considered a disease of the elderly but stroke also occurs in middle-aged people
Thrombolysis with tissue plasminogen activator tPA is the preferred choice of reperfusion therapy of ischemic stroke if performed within 45 hours from symptom onset Time to thrombolysis is associated with improved outcome the sooner the treatment the less risk of serious - and possibly permanent - damage to the brain Unfortunately only a small fraction of stroke patients make it to thrombolysis within the 45-hour one explanation may be system delays including prolonged transportation
In May 2010 the first physician-staffed Helicopter Emergency Medical Service HEMS was implemented in the Eastern part of Denmark An observational study evaluating the short-term effects of HEMS implementation compared patients transported by conventional ground ambulance Ground Emergency Medical Service GEMS to patients transported by HEMS Patients transported by helicopter had increased time to specialized care However both 30-day and 1-year mortality was slightly lower in patients transported by HEMS although not significant as was the degree of disability at three months measured by the modified Rankin Scale mRS
Thrombolysis with tissue plasminogen activator tPA is the preferred choice of reperfusion therapy of ischemic stroke if performed within 45 hours from symptom onset Time to thrombolysis is associated with improved outcome the sooner the treatment the less risk of serious - and possibly permanent - damage to the brain Unfortunately only a small fraction of stroke patients make it to thrombolysis within the 45-hour one explanation may be system delays including prolonged transportation
In May 2010 the first physician-staffed Helicopter Emergency Medical Service HEMS was implemented in the Eastern part of Denmark An observational study evaluating the short-term effects of HEMS implementation compared patients transported by conventional ground ambulance Ground Emergency Medical Service GEMS to patients transported by HEMS Patients transported by helicopter had increased time to specialized care However both 30-day and 1-year mortality was slightly lower in patients transported by HEMS although not significant as was the degree of disability at three months measured by the modified Rankin Scale mRS
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None